DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-07
DOI
10.3389/fphar.2020.01161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity
- (2020) Tania Romacho et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions
- (2020) Shiying Shao et al. PHARMACOLOGY & THERAPEUTICS
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
- (2020) Bolin Wang et al. Aging-US
- Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
- (2020) Furong Qi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
- (2020) Concepción Peiró et al. CIRCULATION
- Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
- (2020) Bo Li et al. Clinical Research in Cardiology
- COVID-19 and diabetes: Can DPP4 inhibition play a role?
- (2020) Gianluca Iacobellis DIABETES RESEARCH AND CLINICAL PRACTICE
- COVID-19 and diabetes management: What should be considered?
- (2020) Antonio Ceriello et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?
- (2020) Dario Pitocco et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
- (2020) Daniel J Drucker ENDOCRINE REVIEWS
- Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
- (2020) Janice Wang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
- (2020) Thomas J. Oxley et al. NEW ENGLAND JOURNAL OF MEDICINE
- High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation
- (2020) Arthur Simonnet et al. Obesity
- Prevalence and impact of diabetes among people infected with SARS-CoV-2
- (2020) G. P. Fadini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- More clinical warning indicators should be explored for monitoring COVID-19 patients' condition
- (2020) Chaojun Yang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Commentary: COVID-19 in patients with diabetes
- (2020) Michael A. Hill et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity
- (2020) David C. Klonoff et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
- (2020) Hong-Long Ji et al. PHYSIOLOGICAL REVIEWS
- Severe COVID-19 infection associated with endothelial activation
- (2020) Robert Escher et al. THROMBOSIS RESEARCH
- A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe
- (2020) Alberto Borobia et al. Journal of Clinical Medicine
- Serum protein signature of coronary artery disease in type 2 diabetes mellitus
- (2019) Ramu Adela et al. Journal of Translational Medicine
- The angiotensin-(1-7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation
- (2019) Alejandra Romero et al. AGING CELL
- Dipeptidyl peptidase-4 inhibitors and cardiovascular and renal disease in type 2 diabetes: What have we learned from the CARMELINA trial?
- (2019) Nordin MJ Hanssen et al. Diabetes & Vascular Disease Research
- Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease
- (2019) Juliana Isa Beraldo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Correspondence
- (2019) C. Yu BRITISH JOURNAL OF SURGERY
- Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus
- (2019) Barchetta I et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome
- (2019) Yochai Birnbaum et al. BASIC RESEARCH IN CARDIOLOGY
- Discovery, synthesis, and in vitro evaluation of a novel bioactive peptide for ACE and DPP-IV inhibitory activity
- (2019) Arpitha Ashok et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme
- (2019) Mohamed Abouelkheir et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Diabetic lung disease: fact or fiction?
- (2019) Saeed Kolahian et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors
- (2018) Angelo Avogaro et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cardiovascular Effects of New Oral Glucose-Lowering Agents
- (2018) André J. Scheen CIRCULATION RESEARCH
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?
- (2018) A. Niraula et al. BMC Endocrine Disorders
- Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes
- (2018) John-Michael Gamble et al. Scientific Reports
- Lung Repair and Regeneration in ARDS
- (2018) Jesús Villar et al. CHEST
- Identification of senescent cell surface targetable protein DPP4
- (2017) Kyoung Mi Kim et al. GENES & DEVELOPMENT
- Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
- (2017) Ratnadeep Basu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients
- (2017) Fei Wang et al. MEDICINE
- Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ
- (2017) Ahmed A. Al-Qahtani et al. Oncotarget
- Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer
- (2017) Xianming Fei et al. Biomed Research International
- Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
- (2017) Christian Baumeier et al. Molecular Metabolism
- Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
- (2016) C. Klemann et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Soluble dipeptidyl peptidase-4 induces microvascular endothelial dysfunction through proteinase-activated receptor-2 and thromboxane A2 release
- (2016) Tania Romacho et al. JOURNAL OF HYPERTENSION
- The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
- (2016) Laura A. Villalobos et al. Frontiers in Pharmacology
- Tissue Factor Pathway Inhibitor
- (2015) Alan E. Mast ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- DPP4 in Cardiometabolic Disease: Recent Insights From the Laboratory and Clinical Trials of DPP4 Inhibition
- (2015) J. Zhong et al. CIRCULATION RESEARCH
- DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials
- (2015) Wenjia Yang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- DPP4 in diabetes
- (2015) Diana Röhrborn Frontiers in Immunology
- Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
- (2014) M. Furuhashi et al. AMERICAN JOURNAL OF HYPERTENSION
- Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2
- (2014) Nina Wronkowitz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression
- (2014) Shiori Haga et al. EXPERIMENTAL LUNG RESEARCH
- Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells
- (2014) Diana Röhrborn et al. FEBS LETTERS
- Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes
- (2014) André J. Tremblay et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
- (2014) Belén Picatoste et al. PLoS One
- Therapeutic vaccine against DPP4 improves glucose metabolism in mice
- (2014) Zhengda Pang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
- (2014) Shuai Xia et al. VIRUS RESEARCH
- Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study
- (2014) Kathryn H. Williams et al. Journal of Diabetes
- A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site
- (2013) Mika Nabeno et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin-(1–7) Protects From Experimental Acute Lung Injury
- (2013) Nadine Klein et al. CRITICAL CARE MEDICINE
- Adipose Dipeptidyl Peptidase-4 and Obesity: Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
- (2013) H. Sell et al. DIABETES CARE
- CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus
- (2013) Sang Ah Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody
- (2013) K. Ohnuma et al. JOURNAL OF VIROLOGY
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes
- (2013) Annayya Aroor et al. CardioRenal Medicine
- A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation
- (2012) Jixin Zhong et al. DIABETES
- Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis
- (2012) K. Gooßen et al. DIABETES OBESITY & METABOLISM
- Cardioprotective Effects of Telmisartan against Heart Failure in Rats Induced By Experimental Autoimmune Myocarditis through the Modulation of Angiotensin-Converting Enzyme-2/Angiotensin 1-7/Mas Receptor Axis
- (2012) Vijayakumar Sukumaran et al. International Journal of Biological Sciences
- Vildagliptin inhibits oxidative stress and vascular damage in streptozotocin-induced diabetic rats
- (2012) Sayaka Maeda et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Sitagliptin Exerts an Antinflammatory Action
- (2012) Antoine Makdissi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors
- (2011) C. O. Phillips CANADIAN MEDICAL ASSOCIATION JOURNAL
- Protease-Resistant Stromal Cell–Derived Factor-1 for the Treatment of Experimental Peripheral Artery Disease
- (2011) Vincent F.M. Segers et al. CIRCULATION
- Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
- (2011) Zubair Shah et al. CIRCULATION
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
- (2011) D. Lamers et al. DIABETES
- Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse
- (2010) Merlin C. Thomas et al. CIRCULATION RESEARCH
- The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1
- (2010) G. P. Fadini et al. DIABETES CARE
- Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
- (2010) C. F. Deacon DIABETES OBESITY & METABOLISM
- Severe leucopenia associated with Sitagliptin use
- (2010) Dario Pitocco et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Severe Hypoglycemia and Risks of Vascular Events and Death
- (2010) Sophia Zoungas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blockade of CD26-mediated T cell costimulation with soluble caveolin-1-Ig fusion protein induces anergy in CD4 + T cells
- (2009) Kei Ohnuma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses
- (2009) Kalpit A Vora et al. BMC IMMUNOLOGY
- Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema
- (2009) Nancy J. Brown et al. HYPERTENSION
- Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis
- (2008) Xiaopeng Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More